AstraZeneca, a British pharmaceutical giant, has admitted that its Covid-19 vaccine can result ina rare side effectknown as Thrombosis with Thrombocytopenia Syndrome (TTS).T
The multinational pharmaceutical major AstraZeneca has admitted for the first time that its Covishield vaccine can cause rare sid eeffects, according to a report by The Telegraph. AstraZeneca.
ALBAWABA In a significant legal development, pharmaceutical giant AstraZeneca has admitted for the first time, in court documents, that its COVID-19 vac
Covishield TTS: AstraZeneca has acknowledged the potential TTS side effects from its COVID-19 vaccine Covishield, used widely in India. TTS, Thrombosis with Thrombocytopenia Syndrome, is rare but serious, marked by blood clots and low platelet levels. Symptoms include headaches, blurred vision, and chest pain. Dr. Jayadevan emphasizes awareness, stressing early treatment for effective management. AstraZeneca s admission follows reports of TTS linked to adenovirus vector vaccines.